147 related articles for article (PubMed ID: 30273810)
1. The relationship between heparanase levels, thrombus burden and thromboembolism in patients receiving unfractionated heparin treatment for prosthetic valve thrombosis.
Bayam E; Kalçık M; Gürbüz AS; Yesin M; Güner A; Gündüz S; Gürsoy MO; Karakoyun S; Cerşit S; Kılıçgedik A; Candan Ö; Yaman A; Özkan M
Thromb Res; 2018 Nov; 171():103-110. PubMed ID: 30273810
[TBL] [Abstract][Full Text] [Related]
2. Management of prosthetic valve thrombosis with unfractionated heparin.
Kalkan S; Gürsoy MO; Güner A; Kalçık M; Bayam E; Gündüz S; Özkan M
Int J Cardiol; 2024 Jun; 404():131968. PubMed ID: 38503347
[TBL] [Abstract][Full Text] [Related]
3. The role of thrombolysis in the management of left-sided prosthetic valve thrombosis: a study of 85 cases diagnosed by transesophageal echocardiography.
Lengyel M; Vandor L
J Heart Valve Dis; 2001 Sep; 10(5):636-49. PubMed ID: 11603604
[TBL] [Abstract][Full Text] [Related]
4. Thrombolysis is superior to heparin for non-obstructive mitral mechanical valve thrombosis.
Lengyel M; Vegh G; Vandor L
J Heart Valve Dis; 1999 Mar; 8(2):167-73. PubMed ID: 10224577
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of D-dimer levels in patients with prosthetic valve thrombosis: relationship with thrombus burden and cerebrovascular events.
Cerşit S; Gündüz S; Bayam E; Güner A; Kalkan S; Kalçık M; Karakoyun S; Gürsoy MO; Yesin M; Candan Ö; Özkan M
Blood Coagul Fibrinolysis; 2018 Apr; 29(3):294-299. PubMed ID: 29570480
[TBL] [Abstract][Full Text] [Related]
6. Non-obstructive prosthetic heart valve thrombosis (NOPVT): Really a benign entity?
Mutuberría-Urdaniz M; Rodríguez-Palomares JF; Ferreira I; Bañeras J; Teixidó G; Gutiérrez L; Zavala G; González-Alujas MT; Evangelista A; Tornos P; García-Dorado D
Int J Cardiol; 2015 Oct; 197():16-22. PubMed ID: 26113471
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the effectiveness and safety of low-molecular weight heparin versus unfractionated heparin anticoagulation after heart valve surgery.
Bucci C; Geerts WH; Sinclair A; Fremes SE
Am J Cardiol; 2011 Feb; 107(4):591-4. PubMed ID: 21184996
[TBL] [Abstract][Full Text] [Related]
8. In vitro comparison of dabigatran, unfractionated heparin, and low-molecular-weight heparin in preventing thrombus formation on mechanical heart valves.
Maegdefessel L; Linde T; Krapiec F; Hamilton K; Steinseifer U; van Ryn J; Raaz U; Buerke M; Werdan K; Schlitt A
Thromb Res; 2010 Sep; 126(3):e196-200. PubMed ID: 20659761
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial.
Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M
J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322
[TBL] [Abstract][Full Text] [Related]
10. Conservative management of a prosthetic valve thrombosis--report of a successful case.
Sousa C; Almeida J; Dias P; Almeida P; Rangel I; Araújo V; Macedo F; Maciel MJ
Heart Lung Circ; 2014 Oct; 23(10):e207-9. PubMed ID: 24954710
[TBL] [Abstract][Full Text] [Related]
11. Comparison of unfractionated heparin, low-molecular-weight heparin, low-dose and high-dose rivaroxaban in preventing thrombus formation on mechanical heart valves: results of an in vitro study.
Kaeberich A; Reindl I; Raaz U; Maegdefessel L; Vogt A; Linde T; Steinseifer U; Perzborn E; Hauroeder B; Buerke M; Werdan K; Schlitt A
J Thromb Thrombolysis; 2011 Nov; 32(4):417-25. PubMed ID: 21773837
[TBL] [Abstract][Full Text] [Related]
12. The predictive value of the CHA2DS2-VASc score in patients with mechanical mitral valve thrombosis.
Çınar T; Hayıroğlu MI; Tanık VO; Aruğaslan E; Keskin M; Uluganyan M; Öz A; Çağdaş M; Alper AT
J Thromb Thrombolysis; 2018 May; 45(4):571-577. PubMed ID: 29524112
[TBL] [Abstract][Full Text] [Related]
13. A fixed-dose combination of low molecular weight heparin with dihydroergotamine versus adjusted-dose unfractionated heparin in the prevention of deep-vein thrombosis after total hip replacement.
Horbach T; Wolf H; Michaelis HC; Wagner W; Hoffmann A; Schmidt A; Beck H
Thromb Haemost; 1996 Feb; 75(2):246-50. PubMed ID: 8815569
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of a low molecular weight heparin administered intravenously or subcutaneously in comparison with intravenous unfractionated heparin in the treatment of deep venous thrombosis. Certoparin-Study Group.
Kirchmaier CM; Wolf H; Schäfer H; Ehlers B; Breddin HK
Int Angiol; 1998 Sep; 17(3):135-45. PubMed ID: 9821025
[TBL] [Abstract][Full Text] [Related]
15. Use of antithrombotic agents during pregnancy: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Bates SM; Greer IA; Hirsh J; Ginsberg JS
Chest; 2004 Sep; 126(3 Suppl):627S-644S. PubMed ID: 15383488
[TBL] [Abstract][Full Text] [Related]
16. Ultraslow thrombolytic therapy: A novel strategy in the management of PROsthetic MEchanical valve Thrombosis and the prEdictors of outcomE: The Ultra-slow PROMETEE trial.
Özkan M; Gündüz S; Gürsoy OM; Karakoyun S; Astarcıoğlu MA; Kalçık M; Aykan AÇ; Çakal B; Bayram Z; Oğuz AE; Ertürk E; Yesin M; Gökdeniz T; Duran NE; Yıldız M; Esen AM
Am Heart J; 2015 Aug; 170(2):409-18. PubMed ID: 26299240
[TBL] [Abstract][Full Text] [Related]
17. Effects of a low-molecular-weight heparin on thrombus regression and recurrent thromboembolism in patients with deep-vein thrombosis.
Breddin HK; Hach-Wunderle V; Nakov R; Kakkar VV;
N Engl J Med; 2001 Mar; 344(9):626-31. PubMed ID: 11228276
[TBL] [Abstract][Full Text] [Related]
18. A comparative double-blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post-operative venous thromboembolism. The Bemiparin Assessment group.
Kakkar VV; Howes J; Sharma V; Kadziola Z
Thromb Haemost; 2000 Apr; 83(4):523-9. PubMed ID: 10780310
[TBL] [Abstract][Full Text] [Related]
19. Incidence and economic implications of heparin-induced thrombocytopenia in medical patients receiving prophylaxis for venous thromboembolism.
Creekmore FM; Oderda GM; Pendleton RC; Brixner DI
Pharmacotherapy; 2006 Oct; 26(10):1438-45. PubMed ID: 16999654
[TBL] [Abstract][Full Text] [Related]
20. Management of prosthetic valve thrombosis.
Lengyel M
J Heart Valve Dis; 2004 May; 13(3):329-34. PubMed ID: 15222276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
